U heeft gezocht op: Whatman products (Cytiva)

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Final fill for recombinant proteins Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepar...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Success story Avantor accelerates Cell and Gene Therapy (C>) production Avantor Services Lab and production services CHALLENGE A global pharmaceutical company set an ambitious strategic goal of transitioning from Cell and Gene Therapy (C>) con...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...

Microbial based recombinant proteins A wide range of recombinant proteins is produced using microbial (E. coli or yeast) fermentation – often being the preferred production method to drive efficiencies in the production process and to be faster to...

Solon Manufacturing Facility Our manufacturing facility in Solon OH include two buildings totaling 275000 sq. feet . Liquid manufacturing Liquid and aseptic processing Powder blending and processing Cleanroom liquid manufacturing and fill/finish C...

Solutions to manage complexity in global single-use supply chain for vaccines manufacturing Webinar On demand Replay Single-use systems have been proven to enable a more flexible cost-effective approach to manufacturing monoclonal antibodies (mAbs...

Understanding the critical roles of cGMP chemicals and single-use technologies in cell & gene therapy manufacturing Webinar On demand Replay Rapid developments in cell & gene therapy have resulted in recent product approvals bringing these transfo...

Order Entry - How to Upload Do you maintain a list of products outside of the vwr.com web site? Do you wish you had a way to load your list into the Order Entry screen or Shopping Basket? Well here is the solution. The ~~Upload a List of Products~...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Assays for final fill Control is influenced by aseptic procedures followed in the production environment and is adhered to by employee training gowning cleaning and environmental control. Process validation steps are followed to ensure an acceptab...

Final fill for gene therapy To meet these requirements products must be prepared in an ISO Class 5 environment and meet USP71 USP85 and USP758 requirements to be sterile pyrogen-free and particulate-free. They must also be validated for use in sto...

Cleanroom Scientist Your Role Your Challenge Our Services Portfolio Resources About Us Contact Us Take the Risk Out of Your Production When it only takes a single particle to cause disaster in a cleanroom there truly is no room for error. Whether ...

Designing Novel Fluid Sampling Systems for GMP Operations Webinar On demand Replay Sampling is a requirement in every process step of biopharmaceutical manufacturing with an increasing demand on accuracy the closer it comes to final finish. The we...